BridgeBio Pharma Inc (BBIO)

NASDAQ · Biotechnology

83.12
+3.23 (+4.04%)
Updated Aug 18, 3:30 PM ET
AI Rating
Buy
Overall Score
65
Trend
72
Momentum
48
Risk
77

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

BridgeBio Pharma Inc is trading at $83.12, up 4.04% on the session. The 50 day average sits at $77.19 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 46.1, which reads as neutral, and MACD is bearish crossover. Volume is volume spike.

The nearest support is around $78.98 with resistance near $86.32, so that band frames the current range. Average daily movement is roughly $3.07, or about 3.7% of the share price, which is what any stop placement has to allow for. The overall health score of 65 out of 100 combines a trend score of 72, momentum of 48 and a risk score of 77.

Technical indicators

RSI (14)
46.1
neutral
MACD
1.064
bearish crossover
SMA 20
82.64
SMA 50
77.19
SMA 200
--
unknown
ATR (14)
3.07
avg daily range
Support
78.98
Resistance
86.32
Volume vs 20d
1.54x
volume spike
Volatility
25.9%
annualised
1 month
-0.55%
3 months
+14.64%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.